Merck Lumira Biosciences Fund Holds First Closing at $43M
Summary
The newly launched Merck Lumira Biosciences Fund has held its first closing at $43m.The investment vehicle was establised by Global health care leader Merck (which has made a $35m investment) in collaboration with Lumira Capital, Teralys Capital and other partners.The fund, which is targeting $50m, will provide capital to support early stage life science innovation in Québec, Canada.It will be managed by Lumira Capital.FinSMEs 29/03/2012
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected